Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Imani Therapeutics AB
AB
Active
Org 5591949093
Hägervägen 27, 746 34
Bålsta
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Imani Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-1M
-1M
-2M
-2M
2020: -2M
-2M
2020
2021: -2M (0% vs 2020)
-2M
0%
2021
2022: -1M (+50% vs 2021)
-1M
+50%
2022
2023: 0M (+100% vs 2022)
0M
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−2
−89
−525
−1 776
−1 709
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−2
−89
−525
−1 776
−1 709
Net financials
—
—
—
—
—
Profit before tax
−2
−89
−525
−1 776
−1 709
Tax
−0
−0
−0
−0
−0
Net profit
−2
−89
−525
−1 776
−1 709
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
1 250
1 086
214
1 123
1 341
Equity
230
185
214
739
989
Long-term debt
966
0
0
0
0
Short-term debt
53
902
0
384
352
Total debt
1 019
902
—
384
352
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
18,4 %
This company
38,2 %
Market median
This company
Market median
52% below market
2020
2024
Return on equity
−0,9 %
This company
18,4 %
Market median
This company
Market median
105% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
4,43×
This company
0,62×
Market median
This company
Market median
615% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Imani Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
